Last edition
News about " chronic liver disease"
GSK's Efimosfermin Secures FDA Breakthrough and EMA PRIME Status for MASH Treatment
The dual regulatory designations from US FDA and European Medicines Agency fast-track development of GSK’s investigational liver therapy for metabolic dysfunction-associated steatohepatitis.
Chronic Liver Disease | 29/04/2026 | By News Bureau
HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care
HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.
Chronic Liver Disease | 21/01/2026 | By News Bureau | 164
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy